Enzene Partners with Virtuosi to Advance Biologics Workforce

Enzene Biosciences Ltd., a premier Continuously Innovative Development and Manufacturing Organization (CIDMO) for biologics, has entered the immersive learning space by partnering with Virtuosi. Virtuosi have been developed by Quality Executive...

Eli Lilly's Omvoh sustains UC efficacy and safety for four years

Eli Lilly and Company has released new findings showing Omvoh (mirikizumab-mrkz) is the first and only interleukin-23p19 (IL-23p19), used for the treatment of moderately to severely active ulcerative colitis (UC) to report sustained, long-term...

NephroPlus Crosses 500 Clinics, Opens New Unit in Saharanpur

According to the Frost & Sullivan Report 2025, NephroPlus, the largest dialysis service provider in Asia, has crossed a major milestone of over 500 dialysis centers across the globe. Marking this achievement, the company announced the launch...

Sai, Centrix & Agility Form Integrated CMC Partnership

Today, Centrix Pharma Solutions, Sai Life Sciences, and Agility Life Sciences announced the formation of an Integrated CMC Partnership aimed at offering innovative biopharma firms comprehensive Chemistry, Manufacturing, and Controls (CMC) services

WHO asks India for Clarification on Coldrif Syrup Exports

According to the World Health Organisation (WHO), it is expected that a Global Medical Products Emergency Alert regarding Coldrif will be issued only after verification from Indian officials.

ENTOD Launches OCUBIOME, India's First Ocular Probiotic for Eyes

ENTOD Pharmaceuticals announced the release of OCUBIOME, the first ocular probiotic blend in India formulated for healthy eyes. It said its proprietary formulation was developed by its research center in Navi Mumbai. ENTOD Pharmaceuticals...

Alembic Pharma Introduces MinerTox to Enhance Farm Productivity

Alembic Pharmaceuticals Ltd. and Amlan International have jointly declared the launch of MinerTox-Z and MinerTox-A in India. These are the two new feed additive solutions that combat harmful toxins and mai the productivity of poultry farms...

Terumo India Launches FineCross M3 in Cardiology Portfolio

Terumo India, the Indian arm of Terumo Corporation (TSE: 4543), a global leader in medical technology, announced the launch of FineCross M3 Coronary Micro-Guide Catheter in India.

AstraZeneca India Gains Approval for Solid Tumor Therapy

For a second indication, UK pharmaceutical giant AstraZeneca India has obtained expanded approval for its cancer treatment Trastuzumab Deruxtecan

NABL Launches MELT Labs Programme for Last-Mile Healthcare

The National Accreditation Board for Testing and Calibration Laboratories (NABL) has initiated the Medical Entry Level Testing (MELT) Labs Programme to propagate quality practices in medical testing laboratories throughout India.

on the deck


Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.